Cargando…

Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis

OBJECTIVE: To evaluate the association between regulatory drug safety advisories and changes in drug utilisation. DESIGN: We conducted controlled, interrupted times series analyses with administrative prescription claims data to estimate changes in drug utilisation following advisories. We used rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrow, Richard L, Mintzes, Barbara, Souverein, Patrick C, De Bruin, Marie L, Roughead, Elizabeth Ellen, Lexchin, Joel, Kemp-Casey, Anna, Puil, Lorri, Sketris, Ingrid, Mangin, Dee, Hallgreen, Christine E, Pearson, Sallie-Anne, Lopert, Ruth, Bero, Lisa, Ofori-Asenso, Richard, Gnjidic, Danijela, Sarpatwari, Ameet, Perry, Lucy T, Dormuth, Colin R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899478/
https://www.ncbi.nlm.nih.gov/pubmed/35058332
http://dx.doi.org/10.1136/bmjqs-2021-013910
_version_ 1784663925843820544
author Morrow, Richard L
Mintzes, Barbara
Souverein, Patrick C
De Bruin, Marie L
Roughead, Elizabeth Ellen
Lexchin, Joel
Kemp-Casey, Anna
Puil, Lorri
Sketris, Ingrid
Mangin, Dee
Hallgreen, Christine E
Pearson, Sallie-Anne
Lopert, Ruth
Bero, Lisa
Ofori-Asenso, Richard
Gnjidic, Danijela
Sarpatwari, Ameet
Perry, Lucy T
Dormuth, Colin R
author_facet Morrow, Richard L
Mintzes, Barbara
Souverein, Patrick C
De Bruin, Marie L
Roughead, Elizabeth Ellen
Lexchin, Joel
Kemp-Casey, Anna
Puil, Lorri
Sketris, Ingrid
Mangin, Dee
Hallgreen, Christine E
Pearson, Sallie-Anne
Lopert, Ruth
Bero, Lisa
Ofori-Asenso, Richard
Gnjidic, Danijela
Sarpatwari, Ameet
Perry, Lucy T
Dormuth, Colin R
author_sort Morrow, Richard L
collection PubMed
description OBJECTIVE: To evaluate the association between regulatory drug safety advisories and changes in drug utilisation. DESIGN: We conducted controlled, interrupted times series analyses with administrative prescription claims data to estimate changes in drug utilisation following advisories. We used random-effects meta-analysis with inverse-variance weighting to estimate the average postadvisory change in drug utilisation across advisories. STUDY POPULATION: We included advisories issued in Canada, Denmark, the UK and the USA during 2009–2015, mainly concerning drugs in common use in primary care. We excluded advisories related to over-the-counter drugs, drug-drug interactions, vaccines, drugs used primarily in hospital and advisories with co-interventions within ±6 months. MAIN OUTCOME MEASURES: Change in drug utilisation, defined as actual versus predicted percentage change in the number of prescriptions (for advisories without dose-related advice), or in the number of defined daily doses (for dose-related advisories), per 100 000 population. RESULTS: Among advisories without dose-related advice (n=20), the average change in drug utilisation was −5.83% (95% CI −10.93 to –0.73; p=0.03). Advisories with dose-related advice (n=4) were not associated with a statistically significant change in drug utilisation (−1.93%; 95% CI −17.10 to 13.23; p=0.80). In a post hoc subgroup analysis of advisories without dose-related advice, we observed no statistically significant difference between the change in drug utilisation following advisories with explicit prescribing advice, such as a recommendation to consider the risk of a drug when prescribing, and the change in drug utilisation following advisories without such advice. CONCLUSIONS: Among safety advisories issued on a wide range of drugs during 2009–2015 in 4 countries (Canada, Denmark, the UK and the USA), the association of advisories with changes in drug utilisation was variable, and the average association was modest.
format Online
Article
Text
id pubmed-8899478
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88994782022-03-22 Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis Morrow, Richard L Mintzes, Barbara Souverein, Patrick C De Bruin, Marie L Roughead, Elizabeth Ellen Lexchin, Joel Kemp-Casey, Anna Puil, Lorri Sketris, Ingrid Mangin, Dee Hallgreen, Christine E Pearson, Sallie-Anne Lopert, Ruth Bero, Lisa Ofori-Asenso, Richard Gnjidic, Danijela Sarpatwari, Ameet Perry, Lucy T Dormuth, Colin R BMJ Qual Saf Original Research OBJECTIVE: To evaluate the association between regulatory drug safety advisories and changes in drug utilisation. DESIGN: We conducted controlled, interrupted times series analyses with administrative prescription claims data to estimate changes in drug utilisation following advisories. We used random-effects meta-analysis with inverse-variance weighting to estimate the average postadvisory change in drug utilisation across advisories. STUDY POPULATION: We included advisories issued in Canada, Denmark, the UK and the USA during 2009–2015, mainly concerning drugs in common use in primary care. We excluded advisories related to over-the-counter drugs, drug-drug interactions, vaccines, drugs used primarily in hospital and advisories with co-interventions within ±6 months. MAIN OUTCOME MEASURES: Change in drug utilisation, defined as actual versus predicted percentage change in the number of prescriptions (for advisories without dose-related advice), or in the number of defined daily doses (for dose-related advisories), per 100 000 population. RESULTS: Among advisories without dose-related advice (n=20), the average change in drug utilisation was −5.83% (95% CI −10.93 to –0.73; p=0.03). Advisories with dose-related advice (n=4) were not associated with a statistically significant change in drug utilisation (−1.93%; 95% CI −17.10 to 13.23; p=0.80). In a post hoc subgroup analysis of advisories without dose-related advice, we observed no statistically significant difference between the change in drug utilisation following advisories with explicit prescribing advice, such as a recommendation to consider the risk of a drug when prescribing, and the change in drug utilisation following advisories without such advice. CONCLUSIONS: Among safety advisories issued on a wide range of drugs during 2009–2015 in 4 countries (Canada, Denmark, the UK and the USA), the association of advisories with changes in drug utilisation was variable, and the average association was modest. BMJ Publishing Group 2022-03 2022-01-20 /pmc/articles/PMC8899478/ /pubmed/35058332 http://dx.doi.org/10.1136/bmjqs-2021-013910 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Morrow, Richard L
Mintzes, Barbara
Souverein, Patrick C
De Bruin, Marie L
Roughead, Elizabeth Ellen
Lexchin, Joel
Kemp-Casey, Anna
Puil, Lorri
Sketris, Ingrid
Mangin, Dee
Hallgreen, Christine E
Pearson, Sallie-Anne
Lopert, Ruth
Bero, Lisa
Ofori-Asenso, Richard
Gnjidic, Danijela
Sarpatwari, Ameet
Perry, Lucy T
Dormuth, Colin R
Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis
title Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis
title_full Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis
title_fullStr Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis
title_full_unstemmed Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis
title_short Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis
title_sort influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899478/
https://www.ncbi.nlm.nih.gov/pubmed/35058332
http://dx.doi.org/10.1136/bmjqs-2021-013910
work_keys_str_mv AT morrowrichardl influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT mintzesbarbara influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT souvereinpatrickc influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT debruinmariel influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT rougheadelizabethellen influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT lexchinjoel influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT kempcaseyanna influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT puillorri influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT sketrisingrid influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT mangindee influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT hallgreenchristinee influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT pearsonsallieanne influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT lopertruth influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT berolisa influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT oforiasensorichard influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT gnjidicdanijela influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT sarpatwariameet influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT perrylucyt influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis
AT dormuthcolinr influenceofdrugsafetyadvisoriesondrugutilisationaninternationalinterruptedtimeseriesandmetaanalysis